Montana Medical Association Prescription Drug Abuse Prevention Training- with 7.5 AMA PRA Catagory 1 Credits

Prescription drug abuse and diversion is a growing epidemic in Montana, contributing to the deaths of more than 300 Montanans each year. The Montana Medical Association and its partners designed this four module course to help health care teams find the proper balance between providing appropriate treatment for patients while protecting them from opioid addiction.

This series provides valuable information for physicians and non-physicians who are involved in patient care concerning opioid medications. Physicians are encouraged to include all appropriate members of their teams in this training. The program addresses the problem on a state and national level, how to prescribe opioids and how to communicate with patients about the dangers of prescription drugs. Non-physicians who complete the webinar and a post-webinar evaluation will also receive a certificate of completion.

Date of Original Release: 7/30/2015
Date of Most Recent Review: 7/30/2019
Termination Date: December 31, 2022

Course Intended For All Specialties: Physicians, Dentists, Physician's Assistants, Pharmacists, Nurses, Nurse Practitioners, Advanced Practice Nurses


Accreditation Statement:

image

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Colorado Medical Society and Montana Medical Association. The Colorado Medical Society is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation: The Colorado Medical Society designates this enduring material for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures: Speakers: Greg Holzman, MD, Tony King, PharmD, Bryan Lockerby, Marc Mentel, DO, Daniel Nauts, MD, Robert Sherrick, MD, Scott Stayner, MD, and David Young, DVM report having no actual or potential conflict of interest in relation to this educational activity.

Planners and other Administrative Support:

Alex Esber, Nina Aiviar, Scot Drake, Elvis Funes, David Sabbath, and Shannon V Simon report having no actual or potential conflict of interest in relation to this educational activity.


Upon conclusion of this activity, participants should be able to:

1. Implement recommended prescribing practices and alternate forms of treatment for patients presenting with acute or chronic pain.

 2 Use the toolkit and resources to manage patient treatment

 3. Apply the state and federal laws as related to prescribing Schedule II drugs

 4. Examine the prescription drug issue from a state and national level

 5. Know the medications used for the treatment of addiction and withdrawal according to DEA regulations and know the disease model of OUD and the importance of identifying and treating it in office, ER and inpatient settings

 6. Implement the use of Medication Assisted Treatment as the standard of care for opioid use disorder, the medications used in MAT and the role of counseling in MAT

 7. Define harm reduction and outcome directed treatment and the concept levels of care of MAT

Dr. Camden Kneeland has reported that he is a clinical researcher for spinal cord stimulation for St. Jude Medical. All others in control of the content of this activity have reported no relevant financial relationships with commercial interests.

Key:

Complete
Failed
Available
Locked
Overview & Introduction
Greg Holzman, MD, MPH, State Medical Officer of Montana, and Marc Mentel, DO, Professor of Family Medicine, discuss the opioid epidemic and substance use disorders. You must register to access.
Clinical Best Practices
Learn about clinical best practices to prevent prescription drug abuse. Featuring Marc C. Mentel, D.O. Missoula, Richard S. Stayner, M.D. Billings, and William S. Gallea, M.D. Helena. You must register to access.
Evolution of opioids in Montana
Greg Holzman, MD, MPH, State Medical Officer of Montana, and Robert Sherrick, MD, Internal/Addiction Medicine, discuss the evolution of opioids. You must register to access.
Toolkit
Learn about the tools available to aid you in preventing prescription drug abuse. Featuring Marc C. Mentel, D.O. Missoula, Richard S. Stayner, M.D. Billings, and William S. Gallea, M.D. Helena. You must register to access.
Resources
Learn about the resources available to prevent prescription drug abuse. Featuring Marc C. Mentel, D.O. Missoula, Richard S. Stayner, M.D. Billings, and William S. Gallea, M.D. Helena. You must register to access.
Montana Prescription Drug Registry
Tony King, PharmD, President of the Montana Board of Pharmacy, Robert Sherrick, MD, Internal/Addiction Medicine, and Marc Mentel, DO, Professor of Family Medicine, discuss opioids and the Montana Prescription Drug Registry and why it is important to use this tool. You must register to access.
Community Partners
Learn about community partners. Featuring Marc C. Mentel, D.O. Missoula. You must register to access.
Law Enforcement
Bryan Lockerby, Administrator of Montana’s Division of Criminal Investigation, talks about opioids and drugs in Montana from a law enforcement perspective while providing some historical context. You must register to access.
Targets in the Pain Pathway to Manage Chronic Pain
Learn about targets in the pain pathway to manage chronic pain. Presented by R. Scott Stayner, M.D., Ph.D. Billings. You must register to access.
An Ethical Approach to Current CDC Guidelines on Prescribing Opioids for Chronic Pain
Marc Mentel, DO, Professor of Family Medicine, talks about ethical approaches to the current Centers for Disease Control and Prevention (CDC) guidelines on prescribing opioids for chronic non-cancer pain. You must register to access.
Special Populations
Robert Sherrick, MD, Internal/Addiction Medicine, and Marc Mentel, DO, Professor of Family Medicine, talk about special populations (adolescents, elderly, women, veterans, etc.) and opioid-use disorders. You must register to access.
Prison Population
David Young, MS, Ph.D., Professor & Community Health Specialist at Montana State University and Chaplain at the Gallatin County Detention Center, talks about opioid addiction in the prison population. You must register to access.
Obtaining a Waiver, Part 1 of 2
Daniel Nauts, MD, FASAM, Addiction Medicine/Internal Medicine, Approved Waiver Trainer by the American Society of Addiction Medicine, talks about Medication Assisted Treatment (MAT), the reasons and process of obtaining a MAT Waiver in part one of this two-part series. You must register to access.
Obtaining a Waiver, Part 2 of 2
Daniel Nauts, MD, FASAM, Addiction Medicine/Internal Medicine, Approved Waiver Trainer by the American Society of Addiction Medicine, continues his discussion about Medication Assisted Treatment (MAT), the reasons and process behind a MAT Waiver in part two of this series. You must register to access.
Treating Chronic Pain Patients with Buprenorphine
TrBrett Bell, MD, Family Medicine, talks about treating chronic pain patients with Buprenorphine, including a pharmacological breakdown of Buprenorphine, in part one of this two-part series. You must register to access.
Managing Patients with OUD in the Hospital
Brett Bell, MD, Family Medicine, discusses approaches to treating a patient with an opioid disorder in the hospital in the second part of this series. You must register to access.
Legacy Patients & CDC Guidelines, Part 1 of 2
Marc Mentel, DO, Professor of Family Medicine, talks about the Centers for Disease Control and Prevention (CDC) guidelines regarding legacy patients (those on more than 90 Morphine Milligram Equivalents) in part one of this two-part series. You must register to access.
Legacy Patients & CDC Guidelines, Part 2 of 2
Marc Mentel, DO, Professor of Family Medicine, talks about the Centers for Disease Control and Prevention (CDC) guidelines regarding legacy patients (those on more than 90 Morphine Milligram Equivalents), while providing real-world applications in the second part of this series. You must register to access.
OUD Background & Treatment, 1 of 4
Robert Sherrick, MD, Internal/Addiction Medicine, talks about the background and treatment of Opioid Use Disorder (OUD) in part one of this four-part series. You must register to access.
The Basics of Medication Assisted Treatment, 2 of 4
Robert Sherrick, MD, Internal/Addiction Medicine, talks about the basics of Medication Assisted Treatment (MAT), why opioid addiction is different than other substance addictions, and how to break the cycle of opioid addiction in part two of this four-part series. You must register to access.
MAT Patients in General Medical Care, 3 of 4
Robert Sherrick, MD, Internal/Addiction Medicine, talks about Opioid Use Disorder (OUD) regarding patients in general medical care and shares a case study in part three of this four-part series. You must register to access.
OUD What Constitutes Quality Treatment, 4 of 4
Robert Sherrick, MD, Internal/Addiction Medicine, talks about the right way to treat Opioid Use Disorder (OUD) and what constitutes quality treatment in the fourth video of this series. You must register to access.
MAT Counseling
Robert Sherrick, MD, Internal/Addiction Medicine, discusses the basics of Medication Assisted Treatment (MAT) and how to break the cycle of addiction. You must register to access.
Post Test, Evaluation and CME Certificate
Access to the eeds™ system and complete the course evaluation, post test, and access you CME certificate. You must register to access.